In summary, here we show that ID3 is a master regulator of the immune response to cancer that is necessary and sufficient to orchestrate a potent local macrophage-driven anti-tumour response, and could be harnessed for the treatment of cancer. The gene discussed is ID3; the disease is neoplasm.